HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
VKTX
Viking Therapeutics Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $3.70B
Market Cap
$3.70B
Enterprise Val
$3.00B
P/E Ratio
-10.29
P/B Ratio
5.79
Trailing PEG (1Y)
-0.03
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$639.1M
Return on Equity-48.04%
Return on Assets-45.67%
Current Ratio9.33
Debt/Equity0.00
LT Debt/Equity0.00
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$153.5M
SG&A$11.3M
Operating Expenses$164.7M
Operating Income-$164.7M
Interest Expense$0.00
Tax Expense$0.00
Net Income-$157.7M
EPS (Basic)$-1.39
EPS (Diluted)$-1.39
EBIT-$157.7M
EBITDA-$157.6M
Consolidated Income-$157.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$165.9M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$715.6M
LT Investments$0.00
Property, Plant & Equipment$85.0K
Intangibles$0.00
Non-Current Assets$131.0K
Total Assets$715.7M
Accounts Payable$53.3M
Current Debt$137.0K
Current Liabilities$76.7M
LT Debt$0.00
Non-Current Liabilities$0.00
Total Liabilities$76.7M
Total Debt$137.0K
Retained Earnings-$847.5M
Shareholder Equity$639.1M
Shares Outstanding113,036,344

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$85.3M
Investing Cash Flow$75.6M
Financing Cash Flow$75.1M
CapEx$0.00
Free Cash Flow-$85.3M
Depreciation & Amort.$94.0K
Stock-Based Comp$8.6M
Acquisitions / Disposals$0.00
Investment Activity$75.6M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$75.1M
Dividends Paid$0.00
Net Change in Cash$65.4M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h